Risk-benefit analysis of adalimumab versus methotrexate and placebo for the treatment of moderate to severe psoriasis: Comparison of adverse event-free remission days in the CHAMPION trial

• Book ID: 116585297
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 46 KB
• Volume: 60
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2008.11.775